Synlogic outlines upcoming clinical milestones

Cambridge, mass., jan. 11, 2021 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today outlined significant clinical milestones for 2021 and provided an overview of recent progress. "with three...
SYBX Ratings Summary
SYBX Quant Ranking